Soleno Therapeutics Inc share price logo

Soleno Therapeutics Inc

NASDAQ: SLNO

$53.01

+0.02

(+0.04%)

Live

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 15 May 2026

Soleno Therapeutics Inc Stock Performance

as on May 18, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $52.98
    $53.00
    downward going graph

    0.06%

    Downside

    -0.02%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $29.43
    $90.32
    downward going graph

    44.48%

    Downside

    70.38%

    Upside

    downward going graph

Soleno Therapeutics Inc share price movements today

Previous Close
$52.99
Open
$52.99
Volume
2.2M
Day's Low - High
$52.98 - $53.00
52 Week Low - High
$29.43 - $90.32

Soleno Therapeutics Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Soleno Therapeutics Inc Stock Fundamentals & Key Indicators

Check Soleno Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Soleno Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Soleno Therapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$-NANA0.00%NA
BUY$32.5B416.98%NA0.00%NA
BUY$39.5B114.85%74.0912.55%NA
BUY$111.0B114.72%25.9835.51%NA
BUY$65.8B23.7%15.3429.65%0.5599999999999999%

Analyst Recommendation on Soleno Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Soleno Therapeutics Inc. Average target price of $53

Soleno Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Soleno Therapeutics Inc.

What analysts predicted

-0.02%DOWNSIDE

Target Price

$53

Current Price

$53.01

Analyzed by

12 Analysts

Target

$53.00

Soleno Therapeutics Inc target price $53, a slight downside of -0.02% compared to current price of $53.01. According to 12 analysts rating.

Soleno Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
3
-
-
-
-
-
32
66
91
94
Gross Profit
2
0
0
-
-
-
31
64
90
93
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-11
-21
-21
-76
-55
-43
-4
26
43
31
Net Profit Margin
-327.80%
0.00%
0.00%
0.00%
0.00%
0.00%
-14.42%
39.40%
47.27%
33.17%

Soleno Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
-1,553
-
-
-
-
-
-
-
190
Gross Profit
0
-1,554
-1
-2
-2
-2
-2
-1
-1
187
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-12
-15
-13
-30
-24
-30
-24
-38
-175
20
Net Profit Margin
-831.63%
1.01%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
10.97%

Global Institutional Holdings in Soleno Therapeutics Inc

Funds
Holdings
Citadel Advisors Llc
2.83%
Millennium Management LLC
2.37%
Geode Capital Management, LLC
2.23%
Deep Track Capital, LP
1.92%
The Goldman Sachs Group Inc
1.75%

Soleno Therapeutics Inc News & Key Events

  • img

    Today's Timeline - 06 April

    Mon, 09:51 PM

    -

    Neurocrine Biosciences announces acquisition of Soleno for $53 per share, valuing the deal at approximately $2.9 billion.

    Tue, 03:10 AM

    -

    Soleno Therapeutics closes at $52.26, up 32.31%, following acquisition news; trading volume surged 2,148% above average.

Insights on Soleno Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, SLNO stock has moved up by 34.5%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SLNO has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 264.8% return, outperforming this stock by 294.7%

About Soleno Therapeutics Inc

Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its first commercial product, VYKAT XR (diazoxide choline) extended-release tablets, is a once-daily oral treatment for hyperphagia in adults and children four years of age and older with Prader-Willi syndrome (PWS). VYKAT XR contains diazoxide choline, a potent ATP-sensitive potassium (KATP) channel activator. The KATP channels play a central role in the regulation of a number of physiological processes which may otherwise be dysregulated, contributing to the pathophysiology of several diseases. In the context of the underlying genetic or structural defects in PWS, these pathophysiological processes may cumulatively contribute to increases in appetite and aggressive food seeking, lack of satiety, accumulation of excess body fat and the establishment and perpetuation of the obese state. PWS is a rare, complex genetic neurobehavioral/metabolic disorder.
OrganisationSoleno Therapeutics Inc
E-voting on sharesClick here to vote

FAQs

What is Soleno Therapeutics Inc share price today?

Soleno Therapeutics Inc share price today is $53.01 as on . Soleno Therapeutics Inc share today touched a day high of $53 and a low of $52.98.

What is the 52 week high and 52 week low for Soleno Therapeutics Inc share?

Soleno Therapeutics Inc share touched a 52 week high of $90.32 on and a 52 week low of $29.43 on . Soleno Therapeutics Inc stock price today i.e. is trending at $53.01,which is 41.31% down from its 52 week high and 80.12% up from its 52 week low.

How to invest in Soleno Therapeutics Inc Stock (SLNO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Soleno Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Soleno Therapeutics Inc Shares that will get you 0.0283 shares as per Soleno Therapeutics Inc share price of $53.01 per share as on May 18, 2026 at 8:45 am IST.

What is the minimum amount required to buy Soleno Therapeutics Inc Stock (SLNO) from India?

Indian investors can start investing in Soleno Therapeutics Inc (SLNO) shares with as little as ₹95 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹950.00 in Soleno Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Soleno Therapeutics Inc share’s latest price of $53.01 as on May 18, 2026 at 8:45 am IST, you will get 0.1886 shares of Soleno Therapeutics Inc. Learn more about fractional shares .